Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
322 studies found for:    "Muscular Dystrophies"
Show Display Options
Rank Status Study
1 Recruiting Stem Cell Therapy in Muscular Dystrophy
Condition: Muscular Dystrophy
Intervention: Biological: Stem Cell
2 Completed Tadalafil in Becker Muscular Dystrophy
Condition: Becker Muscular Dystrophy
Interventions: Drug: Tadalafil;   Drug: Placebo
3 Completed High-dose Prednisone in Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Intervention: Drug: Prednisone
4 Withdrawn Drisapersen Duchenne Muscular Dystrophy (DMD) Treatment Protocol
Condition: Muscular Dystrophies
Intervention: Drug: Drisapersen
5 Not yet recruiting An Open-label Extension Study To Evaluate Safety Of PF-06252616 In Boys With Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Intervention: Biological: PF-06252616
6 Recruiting A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of PF-06252616 in Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Interventions: Biological: PF-06252616;   Drug: Placebo
7 Unknown  Study Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Muscular Dystrophy.
Conditions: Muscular Dystrophy;   Duchenne Muscular Dystrophy,
Intervention: Biological: Stem Cell
8 Withdrawn Gene Transfer Clinical Trial for Duchenne Muscular Dystrophy Using rAAVrh74.MCK.GALGT2
Condition: Duchenne Muscular Dystrophy
Interventions: Biological: rAAVrh74.MCK.GALGT2;   Other: PLACEBO (Saline)
9 Unknown  Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Intervention: Biological: human umbilical cord mesenchymal stem cells
10 Terminated Heart Imaging in Children With Muscular Dystrophy
Condition: Muscular Dystrophy
Intervention:
11 Recruiting An Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)
Condition: Duchenne Muscular Dystrophy
Interventions: Drug: Vamorolone 0.25 mg/day/day;   Drug: Vamorolone 0.75 mg/day/day;   Drug: Vamorolone 2.0 mg/day/day;   Drug: Vamorolone 6.0 mg/day/day
12 Recruiting A Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)
Condition: Duchenne Muscular Dystrophy
Interventions: Drug: Vamorolone 0.25 mg/kg/day;   Drug: Vamorolone 0.75 mg/kg/day;   Drug: Vamorolone 2.0 mg/kg/day;   Drug: Vamorolone 6.0 mg/kg/day
13 Active, not recruiting Dose-Titration and Open-label Extension Study of SRP-4045 in Advanced Stage Duchenne Muscular Dystrophy (DMD) Patients
Condition: Duchenne Muscular Dystrophy
Interventions: Drug: SRP-4045;   Drug: Placebo
14 Completed Stem Cell Therapy in Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Intervention: Biological: Stem Cell
15 Unknown  The Efficacy of Using Far Infrared Radiation to Manage Muscular Dystrophies
Condition: Muscular Dystrophies
Intervention: Radiation: Far Infrared Radiation
16 Active, not recruiting Sunphenon Epigallocatechin-Gallate (EGCg) in Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Interventions: Drug: Epigallocatechin-Gallate;   Drug: Placebo
17 Completed Safety Study of Flavocoxid in Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Intervention: Drug: Flavocoxid
18 Recruiting Study of DS-5141b in Patients With Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Intervention: Drug: DS-5141b
19 Unknown  Study Safety and Efficacy of BMMNC for the Patient With Duchenne Muscular Dystrophy
Conditions: Muscular Dystrophy;   Duchenne Muscular Dystrophy
Intervention: Other: Intralesional/ Intravenous of Autologous Stem cells.
20 Completed Phase II Doubleblind Exploratory Study of GSK2402968 in Ambulant Subjects With Duchenne Muscular Dystrophy
Condition: Muscular Dystrophies
Interventions: Drug: GSK2402968;   Drug: matched placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.